Jasper Therapeutics, Inc. · NASDAQ:JSPR
Morgan Stanley reported a 5.00% stake in Jasper Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 6, 2025
Morgan Stanley reported a 5.00% stake in Jasper Therapeutics, Inc., 758,453 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 758,453
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 5.00% | 758,453 |
Source
Related
- Jasper Therapeutics, Inc.
- Morgan Stanley
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G · Morgan Stanley · Feb 11, 2026
- Schedule 13G/A · Morgan Stanley · Nov 7, 2025
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026